Prostate cancer treatment with radio-guided prostate surgery

Radio-guided prostate surgery, also known as PSMA-targeted radiotherapy or PSMA-RGS, is a type of prostate cancer treatment involving a radioactive tracer to identify and target cancer cells in the prostate gland. Before the procedure, the patient may need a CT or PET scan to determine the cancer's extent and location and some blood tests. Chemotherapy or hormone therapy may previously reduce the tumor, making targeting with the radioactive tracer easier. A tracer is injected into a patient's arm vein days before surgery. Tracer accumulates in cancer cells, making them visible throughout the operation. The patient is given general anesthesia. The surgeon uses an imaging gadget to find and remove cancer cells. After surgery, the patient may need radiation or hormone therapy to remove all cancer cells. The patient must also undergo regular monitoring and follow-up care. PSMA-RGS method has a 90% success rate in removing all prostate cancer cells. Because the treatment is guided by imaging technology, it may result in fewer complications and a faster recovery. The radioactive tracer helps the surgeon locate and remove cancer cells with minimal injury to healthy tissue. Because the tracer targets cancer cells, the process can be adjusted to the patient's needs.